NLS Research

Uncategorized - July 23, 2014

Supermaterial gives rejected drugs a new chance

Uppsala University researchers show that the new material Upsalite has great potential for development of new formulations of rejected drugs. Upsalite, presented in 2013, had the highest surface area ever measures for an alkali earth metal carbonate; 800 square meters per gram. According to a new study published in International Journal of Pharmaceutics, the extremely porous magnesium […]

Uncategorized - July 15, 2014

Biotie granted USD 2 million by Michael J. Fox foundation

Finnish biotech company Biotie has received two million dollars from a foundation set up by Hollywood star Michael J. Fox. The grant provides an opportunity to see if Biotie’s SYN120 treatment can slow the progress of dementia in patients with Parkinson’s Disease. The company is now planning a 16-week trial involving 80 patients at about 10 US sites. […]

Uncategorized - July 3, 2014

Movement disorders in young people related to ADHD

Danish researchers have identified a particular genetic mutation that may cause ADHD and Parkinsonism in young people. In the a study, scientists at the University of Copenhagen and the Copenhagen University Hospital have looked closer at a special protein, the dopamine transporter (DAT). It is a transport protein, which controls the effect of dopamine by mediating re-uptake of released […]

Uncategorized - July 3, 2014

Uppsala University gets major funding to recruit international professor

The Swedish Research Council has granted Uppsala University SEK 145 million to recruit Elisabetta Dejana, an internationally wellknown professor within vascular biology. Elisabetta Dejana is a worldleading and highly quoted researcher and is currently Professor of General Pathology at the Department of Biosciences, University of Milan. With the recruit, Uppsala University hopes to strengthen its […]

Uncategorized - June 19, 2014

Akademiska first on gene analysis prediction of serious side effects from statins

Akademiska in Uppsala is the first Swedish hospital laboratory to analyze a certain gene variety that can predict an increased risk of severe muscle side effects during statin treatment. Statins are a common group of colesterol lowering medicines, used by approximately one out of ten adults to treat increased blood lipids and to prevent cardiovascular […]

Uncategorized - June 18, 2014

60 millions to young researchers

The Swedish Foundation for Strategic Research is allocating ten projects SEK 6 millions each in order to widen the recruitment base for younger promising researchers aspiring for top positions. The funding will be allocated for a five-year-period within the scope of the program “Underrepresented gender”. According to the Swedish Foundation for Strategic Research, SFF, the […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.